CTOs on the Move

American Association of Suicidology

www.suicidology.org

 
American Association of Suicidology is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

tgi healthnetworks

tgi healthnetworks is a Nyack, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Management Resource Solutions

Management Resource Solutions is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Microfil

Microfil LLC is a Bridgman, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GoMeyra

An all-in-one fully customizable cloud-based laboratory management solution helping you manage ordering, accessioning, billing, reporting, and inventory management all with a user-friendly employer/provider portal. GoMeyra LIMS is transforming the testing industry with a system that supports operations with greater accessibility, functionality and interconnectivity. Giving labs the power to process test results with faster speeds and efficiency. Labs are able to triple capacity for same-day and give patients direct results in revolutionary times. Patients who test negative will be able to return to work and travel within 24 hours, compared to the 3-7 day quarantined wait period.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.